Kintara warns stockholder vote failure could lead to bankruptcy, delisting

TuHURA Biosciences, Inc./NV

Voting deadline for merger with TuHURA is Sept 19, 2024 at 11:59 p.m. ET; special meeting Sept 20.
If Proposals 3 & 5 don't get majority support, merger cannot close; company may lack capital and seek bankruptcy.
Without approval, common stock likely delisted from Nasdaq Capital Market.
Upon merger close, each share/warrant gets one contingent value right (CVR) tied to REM-001 program milestone.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.